Author + information
- Received April 9, 2020
- Revision received April 21, 2020
- Accepted April 24, 2020
- Published online July 15, 2020.
- Alexandru Marginean, MDa,∗ (, )
- Dalila Masic, PharmDb,
- Yevgeniy Brailovsky, DO MScc,
- Jawed Fareed, PhDd and
- Amir Darki, MD, MSca
- aLoyola University Medical Center, Department of Cardiology, Maywood, Illinois
- bLoyola University Medical Center, Department of Pharmacy, Maywood, Illinois
- cColumbia University Medical Center, Department of Cardiology, New York, New York
- dLoyola University Medical Center, Department of Pathology, Maywood, Illinois
- ↵∗Address for correspondence:
Dr. Alexandru Marginean, Loyola University Medical Center, Division of Cardiology, Building 110, Room 6292, 2160 South First Avenue, Maywood, Illinois 60153.
Acute pulmonary embolism (PE) is a potentially life-threatening manifestation of venous thromboembolic disease. Severe acute respiratory syndrome-coronavirus-2, a novel coronavirus that causes coronavirus disease-2019 (COVID-19), has been associated with an increased risk of thrombosis. We describe the therapeutic challenges of 3 patients presenting with PE and suspected or confirmed COVID-19. (Level of Difficulty: Beginner.)
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Case Reports author instructions page.
- Received April 9, 2020.
- Revision received April 21, 2020.
- Accepted April 24, 2020.
- 2020 The Authors